Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA
Abstract Background Trastuzumab in combination with chemotherapy is the standard first-line (1L) treatment for HER2+ metastatic gastric cancer (mGC) in the USA. Objective This study characterizes the real-world treatment patterns, healthcare resource use (HRU), and costs in patients with HER2+ mGC p...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | Libro |
Publicado: |
Adis, Springer Healthcare,
2023-08-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Internet
Connect to this object online.3rd Floor Main Library
Número de Clasificación: |
A1234.567 |
---|---|
Copia 1 | Disponible |